DeepTek Cut AI Tuberculosis Screening Costs
A new pricing model for 138 countries aims to triple screening capacity to combat tuberculosis mortality.
Updated on Sept. 28, 2026 in Artificial Intelligence
Live Poll
Do you believe lower-cost diagnostic technology significantly increases access to healthcare in low-income nations?
DeepTek has launched a global access pricing model for its AI-powered chest X-ray screening solution, which is now available at one-third of its previous cost. The initiative, which covers 138 low- and middle-income countries, aims to reduce diagnostic bottlenecks caused by global radiologist shortages.
Why it matters
The program addresses a critical health gap in regions where diagnostic shortages hinder tuberculosis detection, potentially allowing national health systems to scale screening within existing budgets. This move follows a year in which 1.23 million people died from tuberculosis globally.
The AI software integrates with existing X-ray hardware to detect more than 20 distinct chest abnormalities. The system supports online, offline, and hybrid deployment, with the annual subscription covering all AI analyses, training, and technical support.
The players
DeepTek
A medical imaging company based in Mumbai that develops AI software for automated diagnostic analysis and clinical workflow optimization.
Unitaid
A global health agency that invests in innovations to prevent, diagnose, and treat major diseases in low- and middle-income countries.
Clinton Health Access Initiative
A global health organization that partners with governments to improve health systems and increase access to life-saving medical technologies.
The details
The software functions by processing X-ray scans through machine learning algorithms designed to flag anomalies indicative of tuberculosis and other lung conditions. By automating the initial image analysis, the tool alleviates the workload for radiologists, who are in short supply across high-burden regions. Health systems deploy the AI by integrating it directly into their current X-ray infrastructure, allowing for immediate analysis in both connected and remote, offline environments.
Timeline
1.23 million tuberculosis deaths were recorded during 2024.
DeepTek officially launched the global access pricing model on September 28, 2026.
The Tech Race
This program aims to address the significant diagnostic gap identified by the World Health Organization's End TB Strategy. By lowering the entry cost for automated detection, DeepTek is competing to become the primary AI-integrated standard in public health screening programs.
National tuberculosis programs in 138 participating countries can now access the software through an annual subscription that replaces higher upfront capital costs. This allows hospital systems to integrate AI into existing X-ray units to instantly augment their diagnostic capacity.
The takeaway
The move demonstrates a shift toward subscription-based, volume-driven pricing in medical AI to overcome regional resource scarcity. Observers should watch for updates on the adoption rate among national health ministries and the resulting shifts in regional tuberculosis screening volumes.
Further reading
Learn more about the latest developments in Artificial Intelligence diagnostic software.
Source note: This article includes information reported by D A I J I W O R L D.
Live Poll
Do you believe lower-cost diagnostic technology significantly increases access to healthcare in low-income nations?
